Antiangiogenic Effects and Mechanisms of trans-Ethyl p-Methoxycinnamate from Kaempferia galonga LHE, Zhi-Heng; GAR-LEE YUE, Grace; BIK-SAN LAU, Clara et al.Journal of agricultural and food chemistry (Print). 2012, Vol 60, Num 45, pp 11309-11317, issn 0021-8561, 9 p.Article

Disparate effects of endostatin on tumor vascular perfusion and hypoxia in two murine mammary carcinomasFENTON, Bruce M; PAONI, Scott F; GRIMWOOD, Brian G et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 4, pp 1038-1046, issn 0360-3016, 9 p.Article

Urotensin-II as an angiogenic factorGUIDOLIN, Diego; ALBERTIN, Giovanna; RIBATTI, Domenico et al.Peptides (New York, NY. 1980). 2010, Vol 31, Num 6, pp 1219-1224, issn 0196-9781, 6 p.Article

δ-Tocotrienol Suppresses VEGF Induced Angiogenesis whereas α-Tocopherol Does NotSHIBATA, Akira; NAKAGAWA, Kiyotaka; SOOKWONG, Phumon et al.Journal of agricultural and food chemistry (Print). 2009, Vol 57, Num 18, pp 8696-8704, issn 0021-8561, 9 p.Article

Pharmacokinetic and pharmacodynamic study of intratumoral injection of an adenovirus encoding endostatin in patients with advanced tumorsLI, H.-L; LI, S; GUAN, Z.-Z et al.Gene therapy (Basingstoke). 2008, Vol 15, Num 4, pp 247-256, issn 0969-7128, 10 p.Article

Therapeutic renaissance of thalidomide in the treatment of haematological malignanciesRIBATTI, D; VACCA, A.Leukemia. 2005, Vol 19, Num 9, pp 1525-1531, issn 0887-6924, 7 p.Article

Syntheses and biological activities of polymers containing methacryloyl-2-oxy-1,2,3-propanetricarboxylic acid or 5-fluorouracilLEE, Sun-Mi; LEE, Neung-Ju; HA, Chang-Sik et al.Journal of applied polymer science. 2004, Vol 94, Num 1, pp 57-64, issn 0021-8995, 8 p.Article

Antiangiogenic effect of bile acid acylated heparin derivativePARK, Kyeongsoon; KIM, Yoo-Shin; GEE YOUNG LEE et al.Pharmaceutical research. 2007, Vol 24, Num 1, pp 176-185, issn 0724-8741, 10 p.Article

Intra-arterial delivery of endostatin gene to brain tumors prolongs survival and alters tumor vessel ultrastructureBARNETT, F. H; SCHARER-SCHUKSZ, M; WOOD, M et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 16, pp 1283-1289, issn 0969-7128, 7 p.Article

Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesisBAHRAMSOLTANI, Mahtab; PLENDL, Johanna.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2007, Vol 115, Num 1, pp 30-46, issn 0903-4641, 17 p.Article

Antiangiogenic and anticancer potential of unsaturated vitamin E (tocotrienol)MIYAZAWA, Teruo; SHIBATA, Akira; SOOKWONG, Phumon et al.Journal of nutritional biochemistry. 2009, Vol 20, Num 2, pp 79-86, issn 0955-2863, 8 p.Article

Synthesis and antimitotic activity of novel 2-methoxyestradiol analogs. Part IIIRAO, Pemmaraju N; CESSAC, James W; BOYD, James W et al.Steroids. 2008, Vol 73, Num 2, pp 171-183, issn 0039-128X, 13 p.Article

S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinomaEL-KHOUEIRY, A. B; RANKIN, C; SIEGEL, A. B et al.British journal of cancer. 2014, Vol 110, Num 4, pp 882-887, issn 0007-0920, 6 p.Article

Antiangiogenic Phytochemicals and Medicinal HerbsJEONG, Soo-Jin; KOH, Wonil; LEE, Eun-Ok et al.PTR. Phytotherapy research. 2011, Vol 25, Num 1, pp 1-10, issn 0951-418X, 10 p.Article

Bevacizumab and Everolimus in the Treatment of Patients With Metastatic Melanoma: A Phase 2 Trial of the Sarah Cannon Oncology Research ConsortiumHAINSWORTH, John D; INFANTE, Jeffrey R; SPIGEL, David R et al.Cancer. 2010, Vol 116, Num 17, pp 4122-4129, issn 0008-543X, 8 p.Article

Emerging Clinical Principles on the Use of Bevacizumab for the Treatment of Malignant GliomasCHAMBERLAIN, Marc C.Cancer. 2010, Vol 116, Num 17, pp 3988-3999, issn 0008-543X, 12 p.Article

A low molecular weight polysaccharide isolated from Agaricus blazei suppresses tumor growth and angiogenesis in vivoNIU, Y. C; LIU, J. C; ZHAO, X. M et al.Oncology reports. 2009, Vol 21, Num 1, pp 145-152, issn 1021-335X, 8 p.Article

Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2SZENTIRMAI, Oszkar; BAKER, Cheryl H; BULLAIN, Szofia S et al.Journal of neurosurgery. 2008, Vol 108, Num 5, pp 979-988, issn 0022-3085, 10 p.Article

Pathogenic angiogenesis in IBD and experimental colitis : new ideas and therapeutic avenuesCHIDLOW, John H; SHUKLA, Deepti; GRISHAM, Matthew B et al.American journal of physiology. Gastrointestinal and liver physiology. 2007, Vol 56, Num 1, issn 0193-1857, G5-G18Article

Targeting Tumorangiogenesis in Lung Cancer by Suppression of VEGF and its Receptor -Results from Clinical Trials and Novel Experimental ApproachesKUHN, H; HAMMERSCHMIDT, S; WIRTZ, H et al.Current medicinal chemistry. 2007, Vol 14, Num 30, pp 3157-3165, issn 0929-8673, 9 p.Article

Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood-retinal barrierNAMBU, H; NAMBU, R; OSHIMA, Y et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 10, pp 865-873, issn 0969-7128, 9 p.Article

Antiangiogenic effect of metronomic paclitaxel treatment in prostate cancer and non-tumor tissue in the same animals: a quantitative studyLENNERNÄS, Bo; ALBERTSSON, Per; DAMBER, Jan-Erik et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2004, Vol 112, Num 3, pp 201-209, issn 0903-4641, 9 p.Article

Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularizationGEHLBACH, P; DEMETRIADES, A. M; YAMAMOTO, S et al.Gene therapy (Basingstoke). 2003, Vol 10, Num 8, pp 637-646, issn 0969-7128, 10 p.Article

The Development of MetAP-2 Inhibitors in Cancer TreatmentYIN, S.-Q; WANG, J.-J; ZHANG, C.-M et al.Current medicinal chemistry. 2012, Vol 19, Num 7, pp 1021-1035, issn 0929-8673, 15 p.Article

Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapyGARRETT, C. R; SIU, L. L; VELASQUEZ, L et al.British journal of cancer. 2011, Vol 105, Num 1, pp 44-52, issn 0007-0920, 9 p.Article